Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell I Edelson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|March 18, 2018
Implementation of an abdominal closure bundle to reduce surgical site infection in patients on a gynecologic oncology service undergoing exploratory laparotomyShaina F Bruce, Danielle N Carr, Elizabeth R Burton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Prevalence and predictors of psychological distress among women with ovarian cancerTina R Norton, Sharon L Manne, Stephen Rubin, et al.
Gynecologic Oncology Reports|May 26, 2021
Implementation of an enhanced recovery protocol in gynecologic oncologyTanvi V Joshi, Shaina F Bruce, Rod Grim, et al.
Cancer Research|September 18, 2004
Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patientsInmaculada Ibanez de Caceres, Cristina Battagli, Manel Esteller, et al.
Obstetrics and Gynecology|August 13, 2019
Disparities Among Cervical Cancer Patients Receiving BrachytherapyShaina F Bruce, Tanvi V Joshi, Inna Chervoneva, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|March 19, 2008
Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasiaCarolyn Y Fang, Suzanne M Miller, Dana H Bovbjerg, et al.
Gynecologic Oncology|September 22, 2016
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice GuidelineAlexi A Wright, Kari Bohlke, Deborah K Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2016
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice GuidelineAlexi A Wright, Kari Bohlke, Deborah K Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline UpdateStéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong, et al.
Gynecologic Oncology|March 8, 2025
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG studyVictoria L Bae-Jump, Michael W Sill, Paola A Gehrig, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|March 18, 2018
Implementation of an abdominal closure bundle to reduce surgical site infection in patients on a gynecologic oncology service undergoing exploratory laparotomyShaina F Bruce, Danielle N Carr, Elizabeth R Burton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Prevalence and predictors of psychological distress among women with ovarian cancerTina R Norton, Sharon L Manne, Stephen Rubin, et al.
Gynecologic Oncology Reports|May 26, 2021
Implementation of an enhanced recovery protocol in gynecologic oncologyTanvi V Joshi, Shaina F Bruce, Rod Grim, et al.
Cancer Research|September 18, 2004
Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patientsInmaculada Ibanez de Caceres, Cristina Battagli, Manel Esteller, et al.
Obstetrics and Gynecology|August 13, 2019
Disparities Among Cervical Cancer Patients Receiving BrachytherapyShaina F Bruce, Tanvi V Joshi, Inna Chervoneva, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|March 19, 2008
Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasiaCarolyn Y Fang, Suzanne M Miller, Dana H Bovbjerg, et al.
Gynecologic Oncology|September 22, 2016
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice GuidelineAlexi A Wright, Kari Bohlke, Deborah K Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2016
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice GuidelineAlexi A Wright, Kari Bohlke, Deborah K Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline UpdateStéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong, et al.
Gynecologic Oncology|March 8, 2025
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG studyVictoria L Bae-Jump, Michael W Sill, Paola A Gehrig, et al.
Pageof 3